Reactive oxygen species driven prodrug-based nanoscale carriers for transformative therapies-Reference-Cited by-同舟云学术

Reactive oxygen species driven prodrug-based nanoscale carriers for transformative therapies

Published:2024 Issue:17 Volume:12 Page:4335-4353
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Vasvani Shyam¹²^ORCID,Vasukutty Arathy¹,Bardhan Rizia³^ORCID,Park In-Kyu¹²⁴^ORCID,Uthaman Saji⁵^ORCID

Affiliation:

1. Department of Biomedical Sciences and BioMedical Sciences Graduate Program (BMSGP), Chonnam National University Medical School, Gwangju 61469, Republic of Korea

2. DR Cure Inc., Hwasun 58128, Republic of Korea

3. Department of Chemical and Biological Engineering, Iowa State University, Ames, Iowa, 50011, USA

4. Center for Global Future Biomedical Scientists at Chonnam National University, Chonnam National University Medical School, Hwasun 58128, Republic of Korea

5. Smart Materials and Devices (SMAD) Division, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, 575018, India

Abstract

Reactive oxygen species (ROS) play a dual role in pathology and therapy. ROS-responsive nanoscale drug carriers offer a promising strategy to leverage elevated ROS levels in diseased tissues for targeted, enhanced therapeutic delivery and efficacy.

Funder

National Research Foundation of Korea

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00647J

Reference195 articles.

1. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment

2. Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution

3. Nano based drug delivery systems: recent developments and future prospects

4. Plant-Based Green Synthesis of Nanoparticles: Production, Characterization and Applications